Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  1.20 7.06% 18.20 574,628 16:35:20
Bid Price Offer Price High Price Low Price Open Price
17.50 18.50 18.00 17.50 17.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.03 -11.14 -4.36 45
Last Trade Time Trade Type Trade Size Trade Price Currency
17:07:49 O 25,000 18.20 GBX

Futura Medical (FUM) Latest News (3)

More Futura Medical News
Futura Medical Takeover Rumours

Futura Medical (FUM) Discussions and Chat

Futura Medical Forums and Chat

Date Time Title Posts
10/8/202015:10FUTURA a winner for 20157,756
01/7/202011:05fum reality29
20/5/202011:49one million4
02/12/201613:27FUM delivering on sex,pain and rock'n'roll11,414

Add a New Thread

Futura Medical (FUM) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-08-10 16:07:4918.2025,0004,550.00O
2020-08-10 15:35:5718.0025,0004,500.00O
2020-08-10 15:35:2018.204,000728.00UT
2020-08-10 15:14:1518.255,413987.87O
2020-08-10 14:44:1017.79664118.09O
View all Futura Medical trades in real-time

Futura Medical (FUM) Top Chat Posts

Futura Medical Daily Update: Futura Medical Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 17p.
Futura Medical Plc has a 4 week average price of 12.25p and a 12 week average price of 12.25p.
The 1 year high share price is 47.50p while the 1 year low share price is currently 7.25p.
There are currently 245,626,926 shares in issue and the average daily traded volume is 391,268 shares. The market capitalisation of Futura Medical Plc is £44,704,100.53.
loobrush: from LSE What next? More cash or just a huge share price rise.Today 12:28 What can be expected next. Clearly they will need cash to do the US trial that the FDA have requested, but do they need it now. My opinion is that they will wait to get the EU approval due out in the next few months first. When they get this the share price will rocket and they will get a deal with one of the Pharma companies for Europe. This deal will probably include the Pharma paying for the US trial with rights to the US market as well if the US trial goes ok . So possibly no more fund raising would be required in this case. In fact with the EU results being not that far way someone could come in at any time to scoop up a deal with FUM at any time. Could be next week or next month-but at todays price the rise could be as much as one of the vavoured covid stocks. Lets see. I'm now in with a 100,000 plus shares and betting ona big win here.
petroc: Share price when jonnybutler said "let the fall recommence" - 16p. Share price when jonnybutler congratulated himself on his good call - 16p.
glavey: "Yes a P_l_a_c_e_b_o that is going to make lots of money for the shareholders" That's dependent on two things, speculators timing pump and dump on the share price (a zero sum game), FUM somehow getting a product to market with sufficient marketing push behind it to convince enough consumers influenced by the hype to buy in to an over the counter product which provides an admission that they suffer from erectile disfunction. Then getting repeat purchases. That's assuming they can get the clinical approvals and someone to take it on. "They used it as a zero dose version in the trials instead of a true placebo..." No, that is and was the placebo! What you are now being asked to swallow is that both samples with and without the active ingredient 'proved' to have a useful effect in a 3rd stage trial. But within that hypothesis there was no 'control'. Similarly the 'magical' effect passed through first and second stage trials without being noticed. " is totally incorrect to call their product a placebo..." Even FUM call it a placebo: "...the last set of results as far as we've seen them were outstanding..." Yes, incomplete, unresolved, and leaving a lot of questions outstanding.
j777j: Share price up on the week.Well up on the year. AGM wed Blockbuster ED device. The fact you use base uneducated language shows you are just scum
j777j: Yes I was being conservative.The co' forecasts would imply a 150p share price being 2.7 x that of liberum.Plus add in Liberum's additional 30p for patent extension and guess what?That implies a share price of 180pHave a nice day.Marvellous weather here on the Atlantic coast
tiananmen: Great day and an excellent result for the long term holders. Somewhere between where Liberum and FUMs share price estimate is where I am happy to hold till, around 80-100
j777j: Co is standing by it's $1billion pa peak sales for med.This is double the liberum estimate,which is understandably conservative. Would imply a share price of 110p versus the 55p Liberum target.Plus add 30p a share (source Liberum)upon grant of patent extension.
christh: People are looking forward to this new Male formula/cream that will help their masculinity. It will drive sales down of pfizer-Viagra and related products . The FUM cream is instant so no pills to swallow and wait. The share price will hit the roof. Hopefully will be in the market soon for everyone to Buy young or old.
pdt: It will be interesting to see how the share price moves over the next 18 months. Value Inflection points of two submissions; EU mid year and FDA at some point. Hopefully followed by approvals within 12 months of that. I suspect territory deals will be struck rather than a global partner and that these could come at any time. Although there are other indications all the value seems to attached to ED. Perhaps a steady rise in the share price as peeps realise the value here or leaps as inflection points are met? Time will tell I guess, I am new here but the risk/reward looks attractive.
j777j: Something for the weekend courtesy Gold dust on lse goldust881,179 posts Potential share price for Futura ? What is the future for Futura's share price. I have detailed below, from info in the results and more particularly from the webcast presentations what news Futura expects to announce during 2018, of which there is quite a lot that will affect the share price. MED2000-Securing of major commercial deal. CSD500-Reasignment of Rights for most of Europe and USA CSD500-Launch in 6 more countries and possibly up to 13. TPR100 & TIB200 -securing of further deals in USA/Europe. So what about the share price. Clearly there is massive potential if all the products end up all on sale at once but leading up to that point I think that announcements of each of the above this year will increase the share price as each one will confirm that progress is being made, some more than others. Clearly with any deal being announced one can expect upfront deal fees which can be substantial and this is what Futura expect as they stated at the results seminar they have no need to raise further cash. Looking at other company deals in these sectors the total upfront fees could easily be in the ?25-40 million range. So what could Futura be worth in a couple of years time. From global sales figures provided by Futura we have the following potential for Futura's market share and earnings. MED 2000 ($1 billion per annum)= ?800 million say @5% royalty is ?40 million pa TPR100 & TIB200 (1/2 billion per annum)=?400 million say @5% royalty is ?20 million pa CSD500 @10% market share of a $6billion pa market is $600 million=?450 million @ 5% royalty rate is ?9 million per annum. That totals to ?69 million per annum. That's the potential. So with an income of that size with minimal overheads the company on a p/e of 10 % would be valued at ?690 million or ?5.56 per share Current company value @ 47p today is appx 57million So the potential is 10 times the current share price. With lots of news this year we could easily see the share price double up with the newsflow and a big bucks rise coming after the current MED 2000 trial results due shortly. News may come at any time so it's a buy at this price now in my view with results due out on 14th March. If any of one of these major deals comes of the share price would double.. Clearly another investor who has done the maths and sees a ten bagger from here.
Futura Medical share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200811 04:22:42